Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
The tumors in these mice showed high expression of cancer stem cell markers CD56 and CD20 ... long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer ...
Cell proliferation was assessed using (3-(4,5 ... using a panel of antibodies covering the expression of chondrogenic marker (ACAN and COL2), angiogenesis marker (VEGF), angiogenesis inhibitor ...
December 2024, immediately following the approval of the world's first mesenchymal stromal cells clinical trial, the U.S. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results